Jacot, W., Cottu, P., Berger, F., Dubot, C., Venat-Bouvet, L., Lortholary, A., . . . Bidard, F. (2019). Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: The CirCe T-DM1 trial. Breast Cancer Res.
Citação norma ChicagoJacot, William, et al. "Actionability of HER2-amplified Circulating Tumor Cells in HER2-negative Metastatic Breast Cancer: The CirCe T-DM1 Trial." Breast Cancer Res 2019.
MLA引文Jacot, William, et al. "Actionability of HER2-amplified Circulating Tumor Cells in HER2-negative Metastatic Breast Cancer: The CirCe T-DM1 Trial." Breast Cancer Res 2019.
警告:這些引文格式不一定是100%准確.